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Abstract Fibronectin (FN), a major extracellular matrix component, enables integrin-mediated
cell adhesion via binding of a5b1, aIIbb3 and av-class integrins to an RGD-motif. An additional
linkage for a5 and aIIb is the synergy site located in close proximity to the RGD motif. We report
that mice with a dysfunctional FN-synergy motif (Fn1syn/syn) suffer from surprisingly mild platelet
adhesion and bleeding defects due to delayed thrombus formation after vessel injury. Additional
loss of b3 integrins dramatically aggravates the bleedings and severely compromises smooth
muscle cell coverage of the vasculature leading to embryonic lethality. Cell-based studies revealed
that the synergy site is dispensable for the initial contact of a5b1 with the RGD, but essential to re-
enforce the binding of a5b1/aIIbb3 to FN. Our findings demonstrate a critical role for the FN
synergy site when external forces exceed a certain threshold or when avb3 integrin levels decrease
below a critical level.
DOI: 10.7554/eLife.22264.001
Introduction
Fibronectin (FN) is a large extracellular matrix (ECM) glycoprotein that triggers biochemical and
mechanical signaling via integrin binding. FN is essential for mammalian development and tissue
regeneration, and can influence disease such as cancer progression. FN is abundant in blood and in
most tissues and is present in provisional matrices of healing wounds and in the stroma of tumors.
FN is secreted as a disulfide-bonded dimer, assembled into fibrils of variable diameters and then
crosslinked into a fibrillar network of variable rigidity (Leiss et al., 2008) that binds to and serves as
a scaffold for numerous other ECM molecules. FN consists of three different repeating Ig-like folded
units, called type I-III modules. Whereas type I and II modules are stabilized by internal disulfide
bonds, the 15 type III repeats of FN lack disulfide bonds, which confers elasticity to FN fibrils and
the ability to modulate fibril rigidity (Erickson, 1994; Oberhauser et al., 2002). The major cell-bind-
ing site in FN is an arginine-glycine-aspartate (RGD) motif located in the 10th type III module
(FNIII10) that is recognized by a5b1, aIIbb3, and av-class integrins. In addition to the RGD motif, FN
harbors the so-called FN synergy site in the FNIII9 module (Obara et al., 1988), which binds a5b1
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and aIIbb3 integrins but not av-class integrins (Bowditch et al., 1994). The synergy site encom-
passes the DRVPPSRN sequence in mouse FN and site directed mutagenesis identified the two argi-
nine residues to be essential for all synergy site-induced functions (Aota et al., 1994;
Friedland et al., 2009; Chada et al., 2006; Nagae et al., 2012).
In vitro studies have shown that the synergy site increases cell spreading (Aota et al., 1991), FN
fibril assembly (Sechler et al., 1997) and platelet adhesion to FN (Chada et al., 2006). Based on the
crystal structures, the RGD motif forms a flexible loop that physically interacts with both the a5 and
b1 integrin subunits, while the synergy site contacts only the head domain of the a subunit
(Redick et al., 2000; Nagae et al., 2012). The synergy site has been studied using protein- and cell-
based assays, which produced different results giving rise to diverse hypotheses regarding the
mechanistic properties. One hypothesis based on ultra-structural analyses of the recombinant a5b1
ectodomain and the FNIII7-10 polypeptide proposes that the synergy site aligns the binding inter-
face of the integrin heterodimer with the RGD motif to increase the on-rate constant (Kon) of a5b1
binding to FN (Leahy et al., 1996; Garcı´a et al., 2002; Takagi et al., 2003). A combination of theo-
retical and cell-based studies with FRET sensors inserted into the linker region between FNIII9 and
FNIII10 concluded that cell-induced forces reversibly stretch the linker, separate the FN-RGD motif
from the synergy site and switch the binding of a5b1 integrins to av-class integrins (Grant et al.,
1997; Krammer et al., 2002). Finally, using a spinning disk device, it was shown that the engage-
ment of the synergy site allows FN-a5b1 bonds (or FN-aIIbb3 bonds on platelets) to resist shear
forces, suggesting that force exposure allows to switch the bonds from a relaxed to a tensioned
state, leading to an extension of the FN-integrin bond lifetime and to adhesion strengthening
(Friedland et al., 2009). Although these in vitro studies highlight the importance of a5b1 and aIIbb3
integrin-binding to the synergy site, the mode of action is still unclear and the apparently important
roles of these interactions have never been scrutinized in vivo using genetic loss-of-function
approaches.
We decided to directly test the role of the synergy site in vivo by substituting critical residues of
the FN-synergy site in mice. We report that mice carrying a homozygous inactivating mutation in the
fibronectin gene (Fn1)-synergy site (Fn1syn/syn) are viable, fertile, show no overt organ defects, how-
ever, display a mild bleeding tendency and delayed thrombus formation after vessel injury. The
lethal intercrosses of Fn1syn/syn mice with b3 integrin (Itgb3)-deficient mice and in vitro assays with
purified FNsyn isolated from the blood of Fn1syn/syn mice revealed three important findings: (i) the
synergy site does not influence the Kon of a5b1 integrin binding to FN-RGD, (ii) the synergy site
strengthens a5b1/aIIbb3 integrin binding to FN upon application of external force such as blood
flow or internal force such as actomyosin pulling forces, and (iii) during force-induced adhesion
strengthening the synergy site binding to a5b1 and av-class integrin binding to FN compensate
each other, at least in part, up to a certain force threshold.
Results
Normal development and prolonged trauma-induced bleeding in
Fn1syn/syn mice
To directly test the in vivo role(s) of the FN synergy site, we generated the Fn1syn allele by substitut-
ing the two arginines (R1374 and R1379) of the synergy motif (DRVPPSRN) in the FN-III9 module with
alanines (A) (Figure 1A and Figure 1—figure supplement 1A–C). Intercrossing of heterozygous
mice (Fn1+/syn), which showed no apparent phenotype, gave rise to homozygous offspring (Fn1syn/
syn) with a normal Mendelian ratio before and after weaning. Fn1syn/syn mice were fertile, had normal
size and weight, and aged normally. The morphology, ultrastructure, and FN distribution in heart
(Figure 1B), liver, kidney, and lung (Figure 1—figure supplement 1D) were indistinguishable
between Fn1syn/syn and control littermates. Blood vessel organization in whole mount ear samples
analyzed by anti-PECAM-1 and anti-aSMA immunostainings revealed no abnormalities (Figure 1C),
and the subendothelial matrix visualized with antibodies to laminin-1, collagen IV and FN, was also
normally organized in Fn1syn/syn mice (Figure 1—figure supplement 1E). Altogether, these data
indicate that the FN synergy site is dispensable for development and postnatal homeostasis.
Soluble plasma (p) FN is required for the stability of blood clots (Ni et al., 2003b). Therefore, we
performed several experiments to test whether platelets require the synergy site to firmly bind FN
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Figure 1. Normal tissue development and prolonged bleeding in Fn1syn/syn mice. (A) Cartoon of FN and the nucleotide point mutations disrupting the
function of the synergy site. (B) Representative images of 3-months-old Fn1 +/+ and Fn1syn/syn heart sections stained with H and E and immunostained
for FN. (C) Confocal images of ear whole-mounts from 3 months-old mice immunostained with anti-PECAM-1 and anti-aSMA to visualize the dermal
endothelial cell tubes and smooth muscle cells. (D) Bleeding time of 3-months-old Fn1+/+ (n = 11) and Fn1syn/syn (n = 11) mice. (E) Platelet counts in
blood samples of Fn1+/+ (n = 18) and Fn1syn/syn (n = 19) mice. (F) FN content in platelets derived from Fn1+/+ (n = 6) and Fn1syn/syn (n = 6) mice relative
to their vinculin levels. (G) Occlusion time of injured arterioles in the cremaster muscle of 3-months-old Fn1+/+ (n = 11) and Fn1syn/syn (n = 11) mice. (H)
Representative still images of the arteriolar occlusion (white:platelets). Values are shown as mean ± SD; statistical significances were calculated using
the Student t-test; **p<0.01 and ***p<0.001.
DOI: 10.7554/eLife.22264.002
The following figure supplements are available for figure 1:
Figure supplement 1. Strategy used to generate the Fn1syn/syn mice and tissue and platelet analysis.
Figure 1 continued on next page
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via their aIIbb3 and a5b1 integrins. We measured tail bleeding time after tail biopsy (Figure 1D)
and found a significant increase from 4.64 ± 1.50 min (mean ± SD) in Fn1+/+ mice to 7.27 ± 1.71 min
in Fn1syn/syn mice (p<0.001). Importantly, blood platelet counts were normal in Fn1syn/syn mice
(Figure 1E). Since aIIbb3 integrins mediate the uptake of pFN into platelet a-granules (Ni et al.,
2003a), we performed Western-blotting with lysates from washed platelets and found that the FN
content was significantly reduced to 70% in platelets from Fn1syn/syn mice (Figure 1F and Figure 1—
figure supplement 2A), while the levels of pFN were similar in Fn1+/+ (318.7 ± 24.1 mg/ml) and
Fn1syn/syn (316.1 ± 31.0 mg/ml) mice (Figure 1—figure supplement 2B).
Importantly, plasma levels of fibrinogen were also similar in Fn1+/+ (2.10 ± 0.17 mg/ml) and
Fn1syn/syn (2.08 ± 0.07 mg/ml) mice. In vitro aggregation of washed platelets, induced with either col-
lagen I, thrombin or ADP, triggered normal shape changes and aggregations (Figure 1—figure sup-
plement 2C–E). To quantitatively study the velocity of thrombus formation in vivo, thrombi
induction was measured in the arterioles of the cremaster muscle upon vessel injury. The experi-
ments revealed a small delay in the onset of thrombus formation in the Fn1syn/syn mice (10.29 ± 9.04
min) that, however, was not significantly different compared to the Fn1+/+ littermates (5.13 ± 3.89
min). In contrast, the time required for arteriole occlusion was significantly increased in Fn1syn/syn
mice (28.56 ± 10.24 min) compared to Fn1+/+ mice (17.82 ± 9.74 min) (Figure 1G). Notably, in 3 out
of 11 Fn1syn/syn mice no total occlusion was observed after 40 min (Figure 1H), a defect that was
never observed in control mice.
These results demonstrate that the synergy site is dispensable for development and postnatal
homeostasis but is required to stabilize platelet clots in vivo and to prevent prolonged bleeding
times.
Fibroblasts delay their focal adhesion maturation on FNsyn
The assembly of FN into a fibrillar network depends on a5b1 binding to FN (Fogerty et al., 1990).
To test whether FN assembly proceeds normally in the absence of the synergy site, we incubated
FN-deficient (Fn1-KO) fibroblasts that express high levels of a5, av, b1 and b3 integrins on their cell
surface (Figure 2—figure supplement 1A) with blood plasma derived from either Fn1+/+ or Fn1syn/
syn mice. In line with our immunostaining of FN in tissues from Fn1syn/syn mice, Fn1-KO cells assem-
bled fibrillar FN networks of indistinguishable complexity, fibril diameter and length with plasma
from Fn1syn/syn and Fn1+/+ mice, respectively (Figure 2A).
Next, we coated glass coverslips with plasma FN (pFN) purified from Fn1+/+ or Fn1syn/syn mice
(Figure 2—figure supplement 1B–E), seeded Fn1-KO fibroblasts and measured adhesion and
spreading (Figure 2B–E). Adhesion of Fn1-KO cells to pFNwt and pFNsyn began around 3 min after
cell seeding and increased with time without noticeable differences (Figure 2—figure supplement
1F). While the formation of nascent adhesions (NAs) was similar on pFNwt and pFNsyn (Figure 2B),
the numbers as well as percentage of paxillin-positive focal adhesions (FAs) linked to stress fibers
were significantly reduced in Fn1-KO fibroblasts seeded for 30 min on pFNsyn (Figure 2D,E) indicat-
ing that the transition from NAs to mature, stress fiber-anchored FAs is delayed on pFNsyn. Further-
more, cell spreading determined as cell area at different time points after cell seeding onto pFNsyn-
coated substrates was also delayed in the first 30 min (Figure 2C). Time-lapse video microscopy con-
firmed the delayed cell spreading on pFNsyn and revealed unstable adhesions consisting of several
cycles of binding and release from the substrate (see Video 1, Video 2 and still images in Figure 2—
figure supplement 2).
These findings indicate that the synergy site is dispensable for FN fibril formation but promotes
the transition from NAs to FAs.
Figure 1 continued
DOI: 10.7554/eLife.22264.003
Figure supplement 2. FN levels in platelets and blood from Fn1syn/syn mice and platelet aggregation assays.
DOI: 10.7554/eLife.22264.004
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Figure 2. The FN synergy site is dispensable for FN fibrillogenesis, cell adhesion and spreading. (A) Fn1-Knock-Out (Fn1-KO) fibroblasts grown in 1%
plasma derived from either Fn1+/+ or Fn1syn/syn mice, fixed at the indicated times and stained for FN (green), F-actin stain (with Phalloidin; red) and
nuclei (with DAPI; blue). Scale bar, 10 mm. (B) Fn1-KO cells seeded on pFNwt or pFNsyn, fixed at the indicated times and stained for F-actin (red), paxillin
(white) and total b1 integrin (green). Scale bar, 20 mm. (C–E) Cell size (C), number of FAs per cell (D) and percentage coverage by FAs (paxillin-positive)
(E) were quantified (n = 25 cells assessed from three independent experiments; mean ± sem). Statistical significances were calculated using the Student
t-test; **p<0.01 and ***p<0.001.
DOI: 10.7554/eLife.22264.005
The following figure supplements are available for figure 2:
Figure supplement 1. Integrin surface levels and plasma FN purification and glass coating.
DOI: 10.7554/eLife.22264.006
Figure supplement 2. Captures of life-time microscopy videos of Fn1-KO fibroblasts spreading on pFNwt or pFNsyn.
DOI: 10.7554/eLife.22264.007
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The FN synergy site is required to
tension FN-a5b1 bonds and to
resist shear forces
It has been reported that HT1080 cells seeded on
the FNIII7-10 polypeptide, increase adhesion
strength to FN upon force application
(Friedland et al., 2009). Therefore, we next
tested whether the force-induced adhesion
strengthening is FN-synergy site-dependent
when Fn1-KO cells adhere to plasma-derived,
purified full-length pFNsyn. We seeded overnight-
starved Fn1-KO fibroblasts for 1 hr onto sub-
strates coated with pFNwt or pFNsyn and recom-
binant FNIII7-10wt or FNIII7-10syn polypeptides,
respectively, and applied a hydrodynamic shear
force with a spinning disk device (Garcı´a et al.,
1998). Typically, the number of Fn1-KO fibroblasts adhering to pFNwt-coated coverslips and spun
for 5 min decreased non-linearly with the applied force and followed a sigmoidal curve (Figure 3—
figure supplement 1), whose inflection point (t50) corresponds to the mean shear stress for 50%
detachment, and hence to a quantitative measure of adhesion strength. Interestingly, the t50 values
of Fn1-KO cells decreased on purified full-length pFNsyn by 16% compared to pFNwt (Figure 3A),
and by 43% on FNIII7-10syn fragment compared to FNIII7-10wt, indicating that cells develop less
adhesion strength on the synergy site-deficient pFN and that higher adhesion strengths arise on full-
length FN compared to FNIII7-10 fragments.
Simultaneous engagement of the RGD motif and the synergy site was suggested to enable a5b1
and aIIbb3 integrins to induce tensioned bonds, which form when receptor and ligand are in close
proximity and hence, can be chemically cross-linked (Shi and Boettiger, 2003). To test the extent of
bond tensioning on pFNsyn, we seeded (15, 30 and 60 min) serum-starved Fn1-KO fibroblasts onto
pFNwt- and pFNsyn-coated substrates, respectively, spun them and treated them with 3,3’-dithiobis
(sulfosuccinimidyl propionate; DTSSP) to crosslink extracellular secondary amines that are within 1.2
nm proximity to each other. We found that the amount of a5 integrins crosslinked to FN in Fn1-KO
fibroblasts was reduced to 60% on pFNsyn (Figure 3B). Upon spinning, Fn1-KO cells increased the
proportion of a5 integrins crosslinked to pFNwt. Importantly, in cells on pFNsyn, the tension was
unable to increase the number of crosslinked bonds upon spinning and their numbers remained at
the same levels as before spinning (Figure 3B), which altogether indicates that the spinning force
strengthens a5b1-mediated adhesion to FN in a synergy site-dependent manner. Furthermore and
in line with a report showing that the conversion of FN-a5b1 bonds from a relaxed to a tensioned
state induces phosphorylation of focal adhesion kinase (FAK) on Y397 (Guan et al., 1991;
Kornberg et al., 1992), pY397-FAK levels were
reduced by 54% when cells were plated on
pFNsyn compared to pFNwt (Figure 3C). Impor-
tantly, phosphorylation of Y861-FAK, which
occurs independent of substrate binding
(Shi and Boettiger, 2003), was indistinguishable
in cells seeded on pFNwt or pFNsyn (Figure 3C).
Since the intensity of FAK Y397 phosphorylation
was shown to operate as a sensor for ECM rigid-
ity (Seong et al., 2013), we conclude that fibro-
blasts attached to pFNsyn perceive insufficient
information regarding substrate stiffness.
av-class integrins compensate for
the absent FN synergy site
Fn1-KO cells express high levels of av-class
integrins (Figure 2—figure supplement 1G),
Video 1. Life-time microscopy video of Fn1KO
fibroblasts on pFNwt.
DOI: 10.7554/eLife.22264.008
Video 2. Life-time microscopy video of Fn1KO
fibroblasts on pFNsyn.
DOI: 10.7554/eLife.22264.009
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which could, at least in part, compensate for the absence of the synergy site during adhesion
strengthening (Figure 3). To test this hypothesis, we seeded pan-integrin-null fibroblasts (pKO)
reconstituted with b1-class integrins to express a5b1 (pKO-b1), or with av integrins (pKO-av) to
express avb3 and avb5 integrins, or with both b1 and av integrins (pKO-av/b1) (Schiller et al.,
2013) on pFNwt- and pFNsyn-coated substrates and evaluated cell adhesion, spreading, and
Figure 3. The FN synergy site is required to establish tensioned FN-a5b1 bonds. (A) Quantification of adhesion
strength. 7  105Fn1-KO cells attached onto purified, full-length (fl) pFNwt or pFNsyn or FNIII7-10wt or FNIII7-10syn
and spun with a spinning disk device (n = 7 independent experiments with fl-FN; n = 3 independent experiments
with FNIII7-10; mean ± sem). (B) Western-blot analysis (left) and quantification (right) of cross-linked a5 integrins to
pFNwt or pFNsyn before and after applying shear forces (n = 6 independent experiments; mean ± sem). (C)
Western-blot analysis (left) and quantification (right) of pY397- and pY861-FAK levels in Fn1-KO cells plated on
pFNwt or pFNsyn (n = 6 independent experiments; mean ± sem). Statistical significances were calculated using the
Student t-test; *p<0.05, **p<0.01 and ***p<0.001.
DOI: 10.7554/eLife.22264.010
The following figure supplement is available for figure 3:
Figure supplement 1. Representative spinning disk experiment showing the cell distribution profile against the
shear force.
DOI: 10.7554/eLife.22264.011
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adhesion site formation. From the three cell lines, only pKO-b1 cells exhibited reduced adhesion on
pFNsyn compared to pFNwt at all-time points analyzed (Figure 4A). Moreover, pKO-b1 cells had sig-
nificantly fewer FAs, contained fewer stress fibers, and spread less on pFNsyn compared to pFNwt
(Figure 4B–F, see Videos 3 and 4 and still images in Figure 4—figure supplement 1). Moreover,
the areas of FAs determined with paxillin and b1 integrin stainings were significantly reduced on
pFNsyn compared to pFNwt (Figure 4G,H), which altogether suggests that pFNsyn-bound a5b1
integrins fail to organize functional adhesion sites and to induce contractile stress fibers required for
cell spreading. pKO-av cells adhered and spread similarly on pFNwt and pFNsyn, and developed
comparably large, paxillin-positive FAs that were anchored to thick stress fibers (Figure 4B,D).
Importantly, pKO-av/b1 cells also showed the same adhesion and spreading behavior, and devel-
oped similar adhesion sites on pFNsyn indicating that av-containing integrins compensate for the
absence of a functional synergy site (Figure 4B,E). Interestingly, the pKO-av/b1 cells do not show a
delay in the transition from NAs to mature FAs on pFNsyn, as we observed with Fn1-KO cells, which
could be due to the significantly higher b3 and lower a5 integrin cell surface levels on pKO-av/b1 as
compared to Fn1-KO cells (Figure 2—figure supplement 1F).
The FN synergy site is dispensable for the on-rate of FN binding to
a5b1 integrins
Electron microscopy studies of the ligand-binding headpiece of integrin a5b1 complexed with frag-
ments of FN indicated no contact with the synergy site region while kinetic data suggested a role of
the synergy site for enhancing the Kon of the complex (Takagi et al., 2003). These findings gave rise
to the hypothesis that the synergy site contributes to accelerate the initial encounter of a5b1 with
FN-RGD, which was in conflict with our observations that adhesion initiation was unaffected in Fn1-
KO cells seeded on pFNsyn (Figure 2—figure supplement 1F). To further test whether the synergy
site is required for the FN binding on-rate, we quantified the probability of pKO-b1, pKO-av, pKO-a
v/b1 and pKO cells binding to FNIII7-10wt or FNIII7-10syn fragments and to purified full-length pFNwt
or pFNsyn using single-cell force spectroscopy (Figure 4I,J). To this end, a single cell was attached to
the ConA-coated cantilever, lowered onto the FN with a speed of 1 mm/s until a contact force of 200
pN was recorded. After a very short contact time of » 50 ms, cell and substrate were separated to
detect the rupture of the few specific bonds formed between integrins and FN. On FNIII7-10wt, the
experiments revealed a 3-fold higher binding probability of pKO-av and pKO-av/b1 cells compared
to pKO-b1 cells, indicating that avb3 integrins have a higher affinity for FN-RGD than a5b1 integ-
rins. Similar results were observed with full-length pFNwt or pFNsyn (Figure 4J). Interestingly, how-
ever, full-length pFN showed higher binding probability than fragments for all cell lines tested
including the pKO cells that lack integrin expression, which altogether suggests that in addition to
integrins also other FN-binding cell surface receptor(s) contribute to the initial binding.
These findings indicate that the FN synergy site promotes the maturation of FAs but accelerates
neither the rates of FN binding to a5b1 integrins nor the formation of NAs.
The FN synergy site compensates for aIIbb3 integrin loss on platelets
To test whether the FN synergy site can also compensate for the loss of b3-class integrin expression
in vivo, we generated homozygous compound mice carrying the Fn1syn mutation and the Itgb3 null
mutation (Itgb3-/-) (Hodivala-Dilke et al., 1999). Itgb3-null mice fail to express the widely expressed
avb3 integrins and the platelet-specific aIIbb3 integrin, and suffer from a bleeding disorder resem-
bling human Glanzmann thrombasthenia. Around 87% of Itgb3-null mice are born and around 40%
of them survive the first year of life (Hodivala-Dilke et al., 1999). To test how the Fn1syn alleles
affect development and survival of Itgb3-/- mice, we intercrossed Fn1syn/+;Itgb3+/- as well as Fn1syn/
syn;Itgb3+/- mice and obtained a total of 245 and 90 live offspring at P21, respectively (Table 1 and
Table 1—source data 1). Out of the 335 offspring altogether, one instead of the expected 38 com-
pound homozygous Fn1syn/syn;Itgb3-/- mice survived to P21. The survivor died at the age of 5 months
from excessive bleeding. To determine the time-point of lethality, embryos were collected at differ-
ent gestation times and genotyped. While compound homozygous Fn1syn/syn;Itgb3-/- embryos were
present at the expected Mendelian distribution until E15.5, no live embryos were present at E16.5
or later. Interestingly, mice with one wild-type Itgb3 allele (Fn1syn/syn;Itgb3-/+) were normally
Benito-Jardo´n et al. eLife 2017;6:e22264. DOI: 10.7554/eLife.22264 8 of 24
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Figure 4. a5b1 integrins require the synergy site in FN to induce cell spreading. (A) Adhesion of pKO-b1, pKO-av and pKO-av/b1 fibroblasts seeded
on pFNwt or pFNsyn for indicated times (n = 3 independent experiments; mean ± sem). (B) pKO-b1, pKO-av and pKO-av/b1 fibroblasts were seeded on
pFNwt or pFNsyn, fixed at the indicated times and stained for total b1 integrin (green), paxillin (white) and F-actin (red). Scale bar, 50 mm. (C–E)
Quantification of cell area of pKO-b1 (C), pKO-av (D) and pKO-av/b1 (E) cells seeded on pFNwt or pFNsyn for indicated times. (F–H) Quantification of
the number of FAs (F), the percentage of FA coverage measured as paxillin-positive area (G) and the percentage of b1 integrin-positive areas referred
to the total cell area (H) in pKO-b1 cells (n = 25 cells for each measurement and three independent experiments; mean ± sem). The binding probability
Figure 4 continued on next page
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distributed, which altogether indicates that one b3 integrin allele is sufficient to compensate for nor-
mal development.
Compound homozygous Fn1syn/syn;Itgb3-/- embryos displayed multiple cutaneous hemorrhages
and edema, which were first visible at E11.5/12.5 (Figure 5A and Figure 5—figure supplement 1A)
and then spread over the whole body at E15.5 (Figure 5B). Interestingly, at E12.5 the bleeds were
visible at sites where the lymphatic vessels form (arrowheads in Figure 5A) and therefore, we
hypothesized that the newly formed lymphatic vessels fail to separate from the cardinal vein, which
occurs between E11-13 (Carramolino et al., 2010). In line with our hypothesis, Lyve1-positive lym-
phatic vessels in the skin of Fn1syn/syn;Itgb3-/- embryos were dilated and covered with ectopic a-
smooth muscle actin (a-SMA)-positive cells and filled with Ter119-positive erythroblasts (Figure 5C–
E). In contrast, lymphatic vessels in the skin of Itgb3-null or wild-type littermates neither contained
Ter119-positive cells nor were surrounded with a-smooth muscle actin-positive cells.
The separation of the primary lymphatic sac from the cardinal vein is driven by platelet adhesion
to and aggregation at the lymphatic endothelium (Carramolino et al., 2010; Uhrin et al., 2010). We
therefore hypothesized that the platelet functions are severely compromised in Fn1syn/syn;Itgb3-/-
embryos as they lack aIIbb3-mediated binding to fibrinogen and FN (Figure 6A), as well as the abil-
ity to strengthen adhesion and signaling via a5b1 integrin-mediated binding to FN. To test the
hypothesis, we performed spreading assays as well as adhesion assays under flow with wild-type or
Itgb3-/- platelets. The mean spreading area of wild-type platelets seeded for 60 min on fibrinogen,
pFNwt, and pFNsyn was 15–16 mm2. As expected, Itgb3-/- platelets failed to spread on fibrinogen
(mean spreading area of 4.6 mm2). Furthermore, they showed a reduced mean spreading area of 8.9
mm2 on pFNwt and failed to spread on pFNsyn (mean spreading area of 3.8 mm2) (Figure 6B,C).
Application of shear flow reduced adhesion of wild-type platelets to pFNsyn by 10-fold compared to
pFNwt, while adhesion of Itgb3-null platelets was lost on fibrinogen as well as pFNsyn, and only
slightly diminished on pFNwt (Figure 6D,E). Importantly, adhesion and spreading of platelets iso-
lated from Itgb3-/- mice to collagen were unaffected, irrespective of whether shear flow was applied
or not (Figure 6C,E).
These in vitro experiments demonstrate that adhesion of aIIbb3-deficient platelets to wild-type
FN is partially compensated by a5b1 integrins in
a FN synergy site-dependent manner, and that
a5b1 as well as aIIbb3 integrins require the FN
synergy site for stabilizing platelet adhesion to
FN, under shear flow.
The FN synergy site compensates
for avb3 during vessel maturation
The absence of a5b1 integrins leads to vascular
defects (Abraham et al., 2008). To test whether
vascular abnormalities due to an impaired a5b1
function contribute to the severe bleeds and the
lethality of Fn1syn/syn;Itgb3-/- embryos, we ana-
lyzed the mural coverage and anchorage to the
ECM. While immunostaining of E11.5 whole
mount embryos with an anti-PECAM-1 antibody
revealed that the vessels in the trunk of Fn1syn/
syn;Itgb3-/- embryos showed normal sprouting
Figure 4 continued
of integrins to FNIII7-10wt or FNIII7-10syn fragments (I) and to full length (fl-FN) pFNwt or pFNsyn (J) determined by single-cell force spectroscopy.
Numbers in parentheses indicate events studied for each condition. Statistical significances were calculated using the Student t-test; *p<0.05, **p<0.01,
***p<0.001 and ****p<0.0001.
DOI: 10.7554/eLife.22264.012
The following figure supplement is available for figure 4:
Figure supplement 1. Captures of life-time microscopy videos of pKO-b1 fibroblasts spreading on pFNwt or pFNsyn.
DOI: 10.7554/eLife.22264.013
Video 3. Life-time microscopy video of pKO-b1
fibroblasts on pFNwt.
DOI: 10.7554/eLife.22264.014
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(Figure 5—figure supplement 1B), the arteries
and veins of the dermal vasculature of E15.5
embryos were tortuous and irregularly covered
with a-SMA-positive cells (Figure 7A). Further-
more, the vascular network was less intricate and
had significantly fewer branching points in
Fn1syn/syn;Itgb3-/- embryos compared to wild-
type littermates (Figure 7B). Interestingly, colla-
gen IV immunostaining indicated that many small
vessels in E15.5 Fn1syn/syn;Itgb3-/- embryos
lacked a clear lumen and PECAM-1 immunosig-
nals (see arrowheads in Figure 7C). They proba-
bly represent retracted vessels and were
significantly more frequent in Fn1syn/syn;Itgb3-/-
embryos compared to wild-type, Fn1syn/syn;
Itgb3+/+ and Fn1+/+;Itgb3-/- littermates
(Figure 7D). Moreover, small vessels in Fn1syn/
syn;Itgb3-/- embryos were often less covered by
pericytes. Instead, NG2-positive pericytes were either detached or formed patchy aggregates on
the vessel surface (see arrowheads in Figure 7E). Altogether, these observations indicate that the
vessel wall coverage and stability are decreased in the Fn1syn/syn;Itgb3-/- embryos and probably con-
tribute to their severe hemorrhages.
Discussion
Although cell-based studies suggested that the FN synergy site is required for aIIbb3 and a5b1
integrin function, the in vivo evidence was missing and the mechanistic property controversial. We
report here the characterization of a mouse strain, in which the synergy site of FN (Fn1syn) was dis-
rupted. Contrary to expectations, the Fn1syn/syn mice were born without developmental defects indi-
cating that the synergy site is dispensable for organogenesis and tissue homeostasis. However,
when Fn1syn/syn mice are exposed to stress such as tail bleeding and arteriole injury, or the genetic
ablation of the FN-binding b3-class integrins (avb3, aIIbb3), the synergy site becomes essential for
cells that have to resist or produce high forces such as platelets and vascular smooth muscle cells
(Figure 8).
Video 4. Life-time microscopy video of pKO-b1
fibroblasts on pFNsyn.
DOI: 10.7554/eLife.22264.015
Table 1. Progeny of Fn1syn/+;Itgb3+/- x Fn1syn/+;Itgb3+/- intercrosses.
Age Num.
Fn1syn/syn
Itgb3+/-
Fn1syn/syn
Itgb3+/+
Fn1syn/syn
Itgb3-/-
Fn1+/syn
Itgb3+/-
Fn1+/syn
Itgb3+/+
Fn1+/syn
Itgb3-/-
Fn1+/+
Itgb3+/-
Fn1+/+
Itgb3+/+
Fn1+/+
Itgb3-/-
E11.5 36 6
(16.7%)
1
(2.8%)
1
(2.8%)
10
(27.8%)
6
(16.7%)
4
(11.1%)
5
(13.9%)
2
(5.6%)
1
(2.8%)
E14.5 23 2
(8.7%)
2
(8.7%)
2
(8.7%)
5
(21.7%)
5
(21.7%)
1
(4.3%)
1
(4.3%)
4
(17.3%)
1
(4.3%)
E15.5 121 12
(9.9%)
5
(4.1%)
3
(2.5%)
39
(32.2%)
5
(15.4%)
12
(9.9%)
14
(11.6%)
17
(14%)
4
(3.3%)
E16.5 16 2
(12.5%)
1
(6.25%)
0 5
(31.5%)
1
(6.25%)
1
(6.25%)
3
(37.5%)
1
(6.25%)
2
(12.5%)
E17.5 16 2
(12.5%)
0 0 6
(23%)
3
(19%)
2
(12.5%)
2
(12.5%)
1
(8%)
0
P 21 245 33
(13.5%)
32
(13%)
0 57
(23%)
46
(18.7%)
13
(5.3%)
35
(14.4%)
17
(3.9%)
12
(4.9%)
Mendelian Distribution 100 12.5% 6.25% 6.25% 25% 12.5% 12.5% 12.5% 6.25% 6.25%
DOI: 10.7554/eLife.22264.016
Source data 1. Progeny of Fn1syn/syn;Itgb3+/- x Fn1syn/syn;Itgb3+/- crosses
DOI: 10.7554/eLife.22264.017
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Ablation of the Fn1 gene in mice, as well as the simultaneous ablations of the Itga5/Itgav integrin
genes in mice arrests development at embryonic day 8.5 (E8.5) due to defects in the formation of
mesoderm and mesoderm-derived structures (George et al., 1993; Georges-Labouesse et al.,
1996; Yang et al., 1999). The replacement of the FNIII10 RGD motif with the RGE in mice also
affects mesoderm development, although less severe and restricted to the vascular system and to
the posterior region of the developing embryo (Takahashi et al., 2007; Giro´s et al., 2011). Interest-
ingly, these defects resemble those observed in Itga5-deficient mice indicating that the RGE muta-
tion is sufficient to abrogate a5b1 integrin function and that the synergy site cannot compensate for
a dysfunctional RGD motif. Furthermore, the normal development of Fn1syn/syn mice also excludes
an essential role of the synergy site for a5 integrin function in vivo (Grant et al., 1997;
Krammer et al., 2002). A reduced a5b1 integrin function would probably have occurred if the syn-
ergy site would indeed guide the binding pocket of a5b1 towards the RGD motif and increase the
FN-binding on-rate (Takagi et al., 2003). However, the absence of obvious ‘a5b1-loss-of-function
defects’ (Yang et al., 1993) in Fn1syn/syn mice and the normal FN-binding on-rates of pKO-b1 cells in
single-cell force spectroscopy experiments indicate that the synergy site is probably dispensable to
accelerate a5b1 integrin-FN binding.
Figure 5. Fn1syn/syn;Itgb3-/- mice suffer from severe hemorrhages and fail to separate the blood and lymphatic vasculatures. (A) E12.5 Fn1syn/syn;Itgb3-/-
embryos display hemorrhages in the jugular and axilar areas in the left side (arrowheads). Scale bar, 50 mm. (B) Representative images from E15.5
littermates embryos resulting from Fn1syn/+;Itgb3-/+ intercrosses. Compound Fn1syn/syn;Itgb3-/- embryos display cutaneous edema (arrowhead) and
abundant skin hemorrhages (arrows); scale bars, 50 mm. (C) Skin whole-mount from E15.5 embryos showing Lyve1-positive lymphatic vessels (green),
aSMA-positive blood vessels (red) and Terr119-positive erythrocytes (white). The lymphatic vessels of compound Fn1syn/syn;Itgb3-/- embryos are dilated,
covered by ectopic aSMA-positive cells and filled with erythrocytes. Scale bar, 50 mm. (D) Representative images of skin sections stained with H and E
(upper panel) and Lyve1 and Terr119 (lower panel) showing erythrocytes in lymphatic vessels. Scale bar, 50 mm. (E) Quantification of the percentage of
lymphatic vessels filled with Ter119-positive erythrocytes (n = 40 vessels counted per embryo, in two embryos per each genotype; mean ± sem).
Statistical significances were calculated using the Student t-test: ****p<0.0001.
DOI: 10.7554/eLife.22264.018
The following figure supplement is available for figure 5:
Figure supplement 1. Blood vessel formation in Fn1syn/syn; Itgb3-/-embryos.
DOI: 10.7554/eLife.22264.019
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We also demonstrate an unexpected, compensatory role between the FN synergy site and avb3
integrins for the vascular coverage by smooth muscle cells. Apparently, the high myosin II-induced
forces generated by these cells are only efficiently absorbed with either high av-class integrin surface
levels or a fully functional FN. Whether a similar functional relationship operates also during paraxial
mesoderm, whose formation critically depends on the expression of a5b1 and av-class integrins
(Yang et al., 1999), cannot be deduced from our experiments. However, the normal mesoderm for-
mation in Fn1syn/syn mice indicates that mesodermal cells require a5b1 to bind the RGD motif but
Figure 6. Shear flow exposed platelets fail to adhere to pFNsyn. (A) Cartoon showing the platelet integrins that can be ligated to the different
substrates used in the experiments. The color intensity of the integrin denotes whether the integrin is active or inactive. (B) Spreading of Itgb3+/+ and
Itgb3-/- platelets after 1 hr on fibrinogen, pFNwt, pFNsyn and type I collagen. Scale bars, 10 mm. (C) Quantification of the platelet area at indicated times
(n = 100 platelets per each condition in three independent experiments; mean ± sem). (D) Representative figures of fluorescently labeled Itgb3+/+ or
Itgb3-/- platelets seeded on indicated substrates and exposed to shear flow. Scale bar, 40 mm. (E) Platelet coverage after 10 min shear flow of 1000 s 1.
(n = 10 pictures per experiment, four independent experiments for each condition; mean ± sem). Statistical significances were calculated using the
Student t-test; *p<0.05, **p<0.01 and ***p<0.001.
DOI: 10.7554/eLife.22264.020
Benito-Jardo´n et al. eLife 2017;6:e22264. DOI: 10.7554/eLife.22264 13 of 24
Research article Cell Biology
Figure 7. Malformed blood vessels in Fn1syn/syn;Itgb3-/- embryos. (A) PECAM-positive endothelial cells (red) and a-
SMA-positive smooth muscle cells (green) in dermal whole mounts from E15.5 Fn1+/+;Itgb3+/+ and Fn1syn/syn;
Itgb3-/- littermate embryos indicate veins (V) and arteries (A). (B) Quantification of the number of branching points
(n = 10–15 images of 2–3 embryos; mean ± sem). (C) Vascular basement membranes in dermal whole mounts from
E15.5 Fn1+/+;Itgb3+/+, Fn1+/+;Itgb3-/- and Fn1syn/syn;Itgb3-/- littermate embryos stained for type IV collagen (green)
and PECAM-positive endothelial cells (red). Arrowheads show small vessels lacking lumen. (D) Quantification of
retracted vessels (n = 14–23 from 4–7 embryos; mean ± sem). (E) PECAM-positive endothelial cells (red) and NG2-
positive pericytes (green) in dermal whole-mounts from E15.5 Fn1+/+;Itgb3+/+, Fn1+/+;Itgb3-/- and Fn1syn/syn;Itgb3-/-
littermate embryos. Note pericytes are sparse, absent or aggregate on mutant vessels (arrowheads). Statistical
significances were calculated using the Student t-test; *p<0.05, and ***p<0.001. Scale bars, 50 mm.
DOI: 10.7554/eLife.22264.021
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not the synergy site. Interestingly, we also find clear evidence for a compensatory role of the FN syn-
ergy site and av-class integrins for cell spreading and FA maturation in vitro (Figure 8), which differs
from previous reports showing that a5b1 and av-class integrins have non-overlapping functions for
inducing myosin contractility (Schiller et al., 2013) or controlling directional migration
(Missirlis et al., 2016).
It is well known that platelet adhesion to pFN, mediated by aIIbb3 with contributions from a5b1
and other integrins, plays a critical role for hemostasis (Wang et al., 2014; Ni et al., 2003b). Our
findings revealed that the FN synergy site is critically important for the adhesion of wild type plate-
lets in in vitro flow chamber settings, while impaired spreading or defects under static adhesion only
arise when aIIbb3 expression is lost. These findings indicate that the synergy site plays a central role
as soon as force is applied to the bonds between FN and platelet integrins. A similar force-depen-
dent requirement of the synergy site was also apparent after arteriolar injuries in vivo, which showed
that Fn1syn/syn mice display diminished platelet adhesion and delayed thrombus formation. This
requirement of the synergy site for platelets to resist the shear forces of the blood flow also provides
a rational explanation for the prolonged bleeding times observed in Fn1syn/syn mice after tail tip exci-
sions. Interestingly, the in vivo platelet dysfunctions in Fn1syn/syn mice as well as Itgb3-/- mice pro-
foundly aggravate in compound Fn1syn/syn;Itgb3-/- embryos where they cause fatal bleedings and an
insufficient platelet-mediated separation of the lymphatic vessels from the cardinal vein. Since
murine platelets contain around 100 times more aIIbb3 than a5b1 integrins (Zeiler et al., 2014) the
Figure 8. The major role of the FN synergy site is to re-enforce cell adhesion. (A) Hydrodynamic shear force-exposed fibroblasts seeded on a FNwt-
coated surface form catch-bonds that strengthen a5b1 integrin-mediated adhesions to FN and trigger phosphorylation of Y397-FAK (upper image). On
FNsyn-coated surfaces, the avb3 integrins compensate for the absent synergy site allowing fibroblast adhesion and the reduced a5b1 binding strength
leads to diminished phosphorylation of pY397-FAK (middle image). The elimination of av-class integrins decreases cell adhesion on FNsyn-coated
surfaces, reduces cell spreading and delays the maturation of FA and fibrillar adhesions (lower image). (B) Platelets in Fn1+/+ mice form tight
aggregates on injured vessel walls that withstand the shear forces of the blood flow (upper image), while platelets in an injured vessel in Fn1syn/syn mice
fail to withstand the blood flow leading to a delayed thrombus formation (lower image). Endothelial cells (EC); vascular smooth muscle cells (VSMC).
DOI: 10.7554/eLife.22264.022
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compensation of the entire aIIbb3 pool by the minor a5b1-FNwt complexes underscores the funda-
mental role of the adhesion strengthening property of the synergy site in FN.
Our mouse strain will allow now to test how the synergy site-mediated adhesion re-enforcement
affects the course of tissue fibrosis or cancer development and progression, which are heavily influ-
enced by integrin surface levels as well as tissue rigidity that in turn is modulated by the strength of
integrin-ligand bonds (Zilberberg et al., 2012; Laklai et al., 2016).
Materials and methods
Animals
Mice were housed in special pathogen free animal facilities. All mouse work was performed in accor-
dance with the Government of the Valencian Community (Spain) guidelines (permission reference
A1327395471346) and with the Government of Upper Bavaria. Mice containing the integrin b3 dele-
tion were bred under the permission reference 55.2-1-54-2532-96-2015. The tail-bleeding and cre-
master muscle venules injury assays performed under the permission reference 55.2-1-54-2532-115-
12.
Generation of Fn1syn/syn knockin mice
A 129/Sv mouse PAC clone was used to construct the targeting vector (Figure 1—figure supple-
ment 1A), which consisted of a 2.1 kb fragment containing exons 26 and 27, a neomycin cassette
flanked by loxP sites, a 2.4 kb fragment containing the exon 28 carrying the mutated nucleotides,
and a 3.5 kb fragment with the exons 29 to 32. The targeting construct was linearized with NotI and
electroporated into R1 embryonic stem (ES) cells. Approximately 300 G418-resistant clones were iso-
lated and screened by Southern blot for homologous recombination. The genomic DNAs were
digested with SacI, XbaI or BstEII and probed with external probes 1 and 2 (Figure 1—figure sup-
plement 1A). Two correctly targeted clones were injected into C57BL/6 host blastocysts to generate
germline chimeras. The Fn1syn-neo/+ mice were crossed with a deleter-Cre strain to eliminate the loxP
flanked neomycin cassette. The elimination of neomycin was analyzed by Southern blot, genomic
DNA was digested with Eco RI and probed with probe 3 (Figure 1—figure supplement 1B). The
Fn1syn/+ mice were intercrossed to generate homozygous Fn1syn/syn mice. The following primers
were used to genotype the mouse strain by PCR: 5’-TCACAAGGAAACCAGGGAAC-3’ (forward); 5’-
CCGTTTTCACTCTCGTCAT-3’ (reverse).
Cell lines
The mouse Fn1-KO cell line and the integrin pan-KnockOut fibroblast lines were isolated from
a mouse kidney and immortalized by retroviral delivery of the SV40 large T. To generate Fn1-KO
cells, the Fn1 gene was deleted from Fn1flox/flox with the adenoviral transduction of the Cre recombi-
nase. Integrin pKO fibroblasts were generated as described by Schiller et al. (2013). Itgavflox/flox;
Itgb1flox/flox; Itgb2-/-;Itgb7-/- immortalized fibroblasts were treated with adenoviral Cre recombinase
and reconstituted with mouse Itgb1 and/or Itgav integrin cDNAs to generate pKO-b1, pKO-av and
pKO-av/b1 cells. The cells were provided by H. Schiller (Max-Planck Institute for Biochemistry, Mar-
tinsried, Germany). Cell lines were not tested for mycoplasma.
Antibodies
For flow cytometry, we used the following antibodies conjugated to PE: 1:200; hamster anti-b1
integrin (102207, from from BioLegend, San Diego, CA, USA), rat anti-a5 integrin (557447, from
from PharMingen, Madrid, Spain), hamster anti-b3 integrin (12–0611, from BD
Bioscience, Madrid, Spain) and rat anti-av integrin (551187, from from PharMingen). For immunos-
tainings or western blots, we used the following antibodies: rabbit anti-b1 integrin (obtained from
Reinhard Fa¨ssler) IF 1:500; rabbit anti-a5 integrin (4705, from Cell Signaling, Barcelona, Spain) WB
1:2000; rabbit anti-pTyr397FAK (44–624G, from Biosource, Madrid, Spain) WB 1:1000; rabbit anti-
pTyr861FAK (44–626G, from Biosource) WB 1:1000; rabbit anti-FAK (06–543, from Millipore, Ille de
France, France) WB 1:1000; rabbit anti-Fibronectin (AB2033, from Millipore) WB 1:2000, IF 1:300–
500; mouse anti-Paxillin (610051, from PharMingen) IF 1:300; rabbit anti-Lyve1 (ab14914, from
Abcam, Cambridge, UK) IF 1:300, WM 1:100; rat anti-Ter119 (09082D, from PharMingen) IF 1:400,
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WM 1:100; rat anti-PECAM (553370, from PharMingen) IF 1:300, WM 1:100; rabbit anti-Collagen IV
(2150–1470, from Bio-Rad, Madrid, Spain) WM 1:100; mouse anti-smooth muscle actin conjugated
with Cy3 (A2547, from Sigma-Aldrich, Madrid, Spain) IF 1:500, WM 1:200; anti-NG2 chondroitin sul-
fate proteoglycan (AB5320, from Merck Millipore) WM 1:100; mouse anti-gamma chain fibrinogen
(ab119948, from Abcam), WB 1:200; rabbit anti-laminin-1 (L9393, from Sigma-Aldrich) WM 1:100.
F-actin was stained with Phalloidin coupled with TRITC (P1951, from Sigma-Aldrich) IF 1:500. For
immunofluorescence the following secondary antibodies were used diluted 1:400: goat anti-rabbit
conjugated with Alexa488 (A11008); goat anti-rabbit conjugated with A546 (A11010); donkey anti-
mouse conjugated with A647 (A31571); goat anti-rat conjugated with A488 (A21208); goat anti-rat
conjugated with A546 (A11081); goat anti-rat conjugated with A647 (A21247) (all from
Invitrogen, Madrid, Spain). For western-blot, goat anti–rabbit conjugated with horseradish peroxi-
dase (172–1019, from Bio-Rad) was used as secondary antibody.
Purification of plasma fibronectin (pFN)
Blood was collected from Fn1+/+ and Fn1syn/syn mice using 0.5 M EDTA as anticoagulant in non-hep-
arinized capillaries, centrifuged at 3000 rpm for 20 min and the pFN was purified from the superna-
tant (plasma) using Gelatin-Sepharose (GE Healthcare Life Sciences, Valencia, Spain) affinity
chromatography (Retta et al., 1999) adapted to minicolumns (Poly-Prep, Bio-Rad). Briefly, the col-
umns were washed with 0.5 NaCl in 10 mM Tris-HCl pH7.4 and pFN was eluted with 2 M urea in TBS
(0.15 M NaCl in 10 mM Tris-HCl, pH 7.4) and dialyzed against TBS. Purified FN was analyzed by 8%
SDS-PAGE and stained with Coomassie brilliant blue, and by Western blot.
Production of the FNIII7-10 fragment
We used the human cDNA encoding the FNIII7-10 fragment and subcloned in the expression vector
pET-15b (Takahashi et al., 2007). To generate the FNIII7-10syn we mutated by site-directed muta-
genesis the two arginines in the synergy sequence: DRVPHSRN>DAVPHSAN. We performed two
rounds of PCR using the following primers: 5´-GATGCGGTGCCCCACTCTCGGAAT-3´ (forward) and
5´-GATGCGGTGCCCCACTCTGCGAAT-3´ (forward) and the complementary reverse primers. The
expression of recombinant FN fragments was done in the E. coli strain Rosetta T1R. Purification was
performed using TALON Metal Affinity chromatography (Clontech, Saint Germain en Laye, France).
Finally the protein was obtained by gel filtration chromatography using Superdex 200 10/300 GL col-
umns (GE Healthcare) and Superdex Size Exclusion Media (GE Healthcare, Valencia, Spain) and
eluted in PBS.
Adsorption of purified pFN onto glass
Glass coverslips of 18 mm diameter were poly-maleic anhydride-1-octadecene (POMA; Polysciences
Inc)-treated (Prewitz et al., 2013) and coated with 0.1–10 mg/ml of purified mouse pFN during 1 hr
at RT, followed by a blocking step of 1 hr using 1% BSA in PBS. To quantify the adsorbed FN, the
coverslips were then incubated for 2 hr at RT with anti-FN antibodies (Ab; diluted 1/300 in blocking
solution), washed, incubated with anti-rabbit Ab conjugated-HRP (diluted 1/500 in blocking solution)
1 hr at RT and finally treated with 50 ml of 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid (ABTS;
Peroxidase substrate kit, Vector SK-4500) for 30 min in the dark. The ABTS-containing solution was
collected and the absorbance was measured at 405 nm.
Cell adhesion assay
96 well plates were coated with 10 mg/ml of pFN or poly-lysine (Sigma-Aldrich, Madrid, Spain) or 3%
BSA in PBS during 1 hr at RT, followed by a blocking step of 30 min using 3% BSA in PBS. The cells
were starved overnight in 9% serum replacement medium (SRM) composed of 46.5% AIM-V (Life
Technologies, Madrid, Spain), 5% RPMI (Life Technologies) and 1% NEAA (Non-Essential Amino
Acid Solution, Sigma-Aldrich) supplemented with 1% FN-depleted calf serum. 5  104 cells were
plated, allowed to adhere for the indicated times and medium was removed and wells washed three
times with PBS. The cells were stained with crystal violet (20% Methanol, 0.1% Crystal Violet) over-
night at 4˚C, washed, 0.1% triton X-100 was added and incubated for 2 hr at RT. Absorbance was
measured at 595 nm.
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Spinning disk assay
The spinning disk assay was done as previously described (Boettiger, 2007) on POMA-treated glass
coverslips of 25 mm diameter, coated with a solution of 10 mg/ml of purified pFN during 1 hr at RT
and afterwards blocked 1 hr with 1% BSA in PBS. The Fn1-KO or HT1080 cells were starved over-
night in 9% SRM supplemented with 1% FN-depleted serum. 7  105 cells were seeded, allowed to
adhere for 1 hr and spun for 5 min at 6000 rpm in Dulbecco´s PBS supplemented with 80 mM CaCl2
and 80 mM MgCl2. After spinning the cells were fixed with 4% PFA and nuclei stained with DAPI.
The nuclei were counted with a Zeiss Axiovert (objective 10x) controlled by Metamorph software,
which allows taking images at determined positions. Data were analyzed as described (Boet-
tiger, 2007). We calculated for each condition the t50, which is the mean force for cell detachment.
pFN-integrin crosslinking assay
Cells were seeded onto pFN-coated glass coverslips and spun and non-spun cells were incubated
with 1 mM 3,3’-dithiobis (sulfosuccinimidyl propionate) (DTSSP; Thermo Scientific, Madrid, Spain)
during 15 min at 4˚C. Quenching was carried out with 50 mM Tris, pH 7.4 for 15 min at RT and cells
were extracted with 20 mM Tris, pH 7.4, 0.1% SDS and proteinase inhibitors
(Inhibitors cocktail, Roche , Barcelona, Spain). Cell lysates were collected and coverslips were thor-
oughly washed with 20 mM Tris, pH 8.5 followed by incubation with 20 mM Tris, pH 8.5, 0.1% SDS
and 25 mM DTT for 1 hr at 37˚C to break the crosslinks. The whole crosslinked fractions and the cell
lysates were separated by SDS-PAGE and transferred to a nitrocellulose membrane. Western-blots
were analyzed with ImageJ and the levels of crosslinked integrins were calculated as the relation
between the crosslinked and the total integrin fractions (cell lysates + crosslinked fraction).
Single-cell force spectroscopy (SCFS)
For cell attachment, cantilevers were plasma cleaned (PDC-32G, Harrick Plasma, Ithaca, NY, USA)
and then incubated overnight at 4˚C in PBS containing ConA (2 mg/ml, Sigma-Aldrich)
(Friedrichs et al., 2013). For substrate coatings, 200 mm thick four-segmented polydimethylsilane
(PDMS) mask fused to the surface of glass bottom Petri dishes (WPI, Sarasota, FL, USA) was used
(Yu et al., 2015). Each of the four PDMS framed glass surfaces were incubated overnight at 4˚C
either with the FNIII7-10wt or FNIII7-10syn fragments or full-length FN (50 mg/ml) in PBS. For SCFS,
we mounted an AFM (Nanowizard II, JPK Instruments, Berlin, Germany) on an inverted fluorescence
microscope (Puech et al., 2006) (Observer Z1/A1, Zeiss, Germany). The temperature was kept at
37˚C throughout the experiment by a Petri dish heater (JPK Instruments,Berlin, Germany). 200 mm
long tip-less V-shaped silicon nitride cantilevers having nominal spring constants of 0.06 N/m (NP-0,
Bruker, USA) were used. Each cantilever was calibrated prior the measurement by determining its
sensitivity and spring constant using the thermal noise analysis of the AFM (Hutter and Bechhoefer,
1993). To adhere a single fibroblast to the AFM cantilever, overnight serum-starved fibroblasts with
confluency up to » 80% were washed with PBS, trypsin-detached for up to 2 min, suspended in
SCFS media (DMEM supplemented with 20 mM HEPES) containing 1% (v/v) FCS, pelleted and resus-
pended in serum free SCFS media. Fibroblasts were allowed to recover for at least 30 min from tryp-
sin treatment. Adhesion of a single fibroblast to the free cantilever end was achieved by pipetting
the fibroblast suspension onto the functionalized Petri dishes. The functionalized cantilever was low-
ered onto a fibroblast with a speed of 1 mm/s until a force of 1 nN was recorded. After » 5 s contact,
the cantilever was retracted with 1 mm/s for 10 mm and the cantilever bound fibroblast was incu-
bated for 7–10 min to assure firm binding to the cantilever. Using differential interference contract
(DIC) microscopy, the morphological state of the fibroblast was monitored. For single molecule sen-
sitivity, the fibroblast bound to the cantilever was lowered onto the coated substrate with a speed
of 1 mm/s until a contact force of 200 pN was recorded for »50 ms contact time. Subsequently, the
cantilever was retracted at 1 mm/s and for 13 mm until the fibroblast and substrate were fully sepa-
rated. After the experimental cycle, the fibroblast was allowed to recover for 0.5 s. For each mea-
surement, the area of the substrate was varied. Force-distance curves were analyzed to determine
binding probability using JPK software. Mann-Whitney tests were applied to determine significant
differences between the binding probability of fibroblast lines at different conditions. Tests were
done using Prism (GraphPad, La Jolla, USA).
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pFAK analysis
Cells were plated on pFN-coated glass coverslips and spun in the spinning disk device, then lysed in
RIPA buffer (50 mM Tris, pH 7.4; 1% NP-40; 0.5% Na-Deoxycolate; 0.1% SDS; 2 mM EDTA) supple-
mented with proteinase inhibitors (Complete Proteinase Inhibitor Cocktail tablet, Roche), phospha-
tase inhibitors (Protease Inhibitors Cocktail 2 Aqueous Solution and Cocktail 3, Sigma-Aldrich), 1
mM Na3VO4 and 5 mM NaF for 10 min on ice, and sonicated for 1 min. The protein concentrations
were quantified using the Pierce BCA Protein Assay Kit (Thermo Scientific) assay and 30–50 mg of
protein were separated by SDS-PAGE gel, transferred to nitrocellulose membranes and hybridized
with specific antibodies. Western-blots were analyzed with ImageJ and the levels of phospho-Tyr397-
FAK or phospho-Tyr861FAK were referred to the total FAK content.
FN matrix assembly assay
Fn1-KO fibroblasts were starved overnight in 9% SRM supplemented with 1% FN-depleted serum,
trypsinized and transferred into 8-well Lab-Tek chambers (Thermo Scientific) coated for 1 hr with a
solution of 20 mg/ml of Laminin (Roche) at RT. After 3 hr, the 9% SRM was supplemented with 1%
mouse plasma and cells were incubated for 24, 48, 72 and 96 hr, fixed with 4% PFA and prepared
for immunofluorescence staining.
Cell spreading assay
Glass coverslips (18  18 mm) were POMA treated, coated with pFN and then incubated with
2  104 Fn1-KO or pKO-b1, pKO-av and pKO-av/b1 cells starved overnight in 9% SRM supple-
mented with 1% FN-depleted serum. After 15, 30, 60 and 120 min of adhesion, cells were fixed with
2% PFA and immunostained. Focal adhesions were quantified with imageJ.
Integrin expression analysis by FACS
Flow cytometry to analyse integrin levels on the Fn1-KO fibroblasts was carried out as previously
described (Theodosiou et al., 2016).
Live imaging of cell spreading
104 cells (Fn1-KO, pKO-b1, pKO-av or pKO-av/b1) were starved overnight, cultured on m-Slide eight
well chambers (Ibidi, Martinsried, Munich) coated with 10 mg/ml of pFN during 1 hr and imaged with
frame rates of 90 s in a Zeiss Axiovert microscope using the VisiView (Visitron
Systems, Puchheim, Germany) software.
Histological analysis
Adult mice were perfused with 4% parafolmaldehyde (PFA) in PBS or tissue pieces and embryos
were fixed overnight with 4% PFA at 4˚C. Fixed tissues were dehydrated in graded alcohol series,
embedded in paraffin (Paraplast X-tra, Sigma-Aldrich), sectioned into 8 mm thick sections and
stained with Haematoxylin-Eosin (H and E) using standard protocols. For immunostainings, sections
were hydrated with inverse graded alcohol series, unmasked by heating in 10 mM citrate buffer (pH
6) for 10 min, blocked for 1 hr with 3% BSA at RT and incubated overnight with the primary anti-
body, washed, incubated with secondary antibodies for 1 hr at room temperature, washed, DAPI
stained and mounted on glass slides with elvanol.
Embryo and skin whole mount immunostaining
Embryos were isolated from pregnant mothers at the stages of E11.5, E15.5 and E16.5 and fixed
overnight at 4˚C with DENT´s fixative consisting of 80% Methanol, 20% DMSO. The skin was dis-
sected after fixation from the E15.5 and E16.5 embryos, washed 3 times with 100% methanol (5 min)
and kept at  20˚C in 100% methanol. For staining, fixed pieces of skin or whole E11.5 embryos
were hydrated in decreasing (75, 50 and 25%) methanol series, diluted in PBS supplemented with
0.1% Tween20 (PBST) and blocked for 2 hr at RT with 3% BSA in PBST. Incubations with primary and
secondary antibodies were done overnight at 4˚C with gentle rocking and after washing with PBST,
tissues were mounted with elvanol.
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Platelet isolation and quantification
Blood from Fn1syn/syn or Fn1+/+ mice was collected in heparinized Microvette CB 300 LH tubes (Sar-
stedt) and platelets were counted using a ProCyte Hematology Analyzer (IDEXX Laboratories, Lud-
wigsburg, Germany). To isolate platelets, heparinized blood from b3+/+ or b3-/- mice was
centrifuged at 70xg for 10 min at RT, the platelet enriched upper phase was then centrifuged at
800xg for 10 min and the platelet pellet was finally washed twice with Tyrodes buffer pH 6.5 (134
mM NaCl, 2.9 mM KCl, 12 mM NaHCO3, 10 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid, 5 mM glucose, 0.35% bovine serum albumin (BSA)). Washed platelets were resuspended in
Tyrodes buffer pH 7.4 and counted using a ProCyte Hematology Analyzer (IDEXX Laboratories). For
experiments, platelet numbers were adjusted to equivalent concentrations with Tyrodes buffer pH
7.4 complemented with 1 mM CaCl2, 1 mM MgCl2.
Platelet aggregation in vitro assays
Platelet aggregation was measured with 1  108 washed platelets stimulated with 0.5 U/ml thrombin
(Sigma-Aldrich) or 5 mg/ml fibrillar type I collagen (Nycomed, Munich, Germany) in the presence of
10 mg/ml pFN isolated either from Fn1+/+ or Fn1syn/syn mice. For platelet aggregation with 20 mM
ADP, platelet rich plasma (PRP) was isolated. The mouse blood was collected with citrate buffer (1:9,
buffer:blood), centrifuged at 110xg and the supernatant (PRP) was collected. A volume of 225 ml of
PRP containing 6.75  107 platelets was used for each experiment adding 20 mM ADP. Light trans-
mission was recorded with a ChronoLog aggregometer over 15 min as arbitrary units with the trans-
mission through buffer defined as 100% transmission.
FN and fibrinogen quantification in isolated platelets and blood plasma
Platelets were isolated from Fn1+/+and Fn1syn/syn heparinized blood as described above. About 5 
106 platelets were lysed with 0,1% Triton in TBS with proteinase inhibitors (Complete Proteinase
Inhibitor Cocktail tablet, Roche) during 10 min on ice. After centrifugation at 13,000 rpm, the super-
natant was run in an 8% SDS-PAGE under reducing conditions, transferred to nitrocellulose mem-
branes and incubated with anti-FN antibodies. To quantify the plasma content of FN and fibrinogen,
2 ml of plasma were loaded onto the 8% SDS-PAGE. As a reference, we used pure human pFN (Milli-
pore) and human fibrinogen (Sigma-Aldrich). Western-blots were analyzed with ImageJ. To know the
FN levels in platelets derived from the different mouse strains the FN levels were related to their vin-
culin contents.
Platelet spreading assay
To study platelet spreading, glass bottom dishes were coated with 10 mg/ml of pFNwt, pFNsyn, fibrin-
ogen (Sigma-Aldrich) or soluble collagen type I (PureCol, Advanced Biomatrix, San Diego, CA, USA)
at RT for 1 hr and blocked with 1% BSA in PBS. Washed platelets (0.5–1  106) were added to the
dishes in a final volume of 1 ml and activated with 0.01% thrombin (Sigma-Aldrich). Images were
taken after 15, 30 and 60 min under a differential interference contrast microscopy (Zeiss Axiovert
200M microscope with a Plan-NEOFLUAR,100, 1.45 oil objective; Zeiss, Jena, Germany) using the
Metamorph software (Molecular Devices, Sunnyvale, CA, USA). The platelet spreading area was ana-
lysed using the ImageJ software.
Platelets adhesion assay under flow
Flow chamber experiments were carried out as described previously (Schulz et al., 2009) using the
air-driven continuous flow pump system from Ibidi. Briefly, platelets were isolated, fluorescently
labelled with 5 mM carboxyfluorescein succinimidyl ester (CFSE; Invitrogen) in Tyrodes buffer pH 6.5
for 15 min and then washed. To achieve near-physiological conditions during perfusion of the pFN-
coated flow chamber slides, 2 ml of washed platelets with a platelet count of 1  107 were com-
bined with 1 ml of human erythrocytes isolated from the blood of a healthy volunteer.
For each experiment, 4 channels of a flow chamber slide (m-Slide VI 0.1 ibiTreat, Ibidi) were
coated with 10 mg/ml fibrillar collagen, fibrinogen, pFNwt or pFNsyn over night at 4˚C and blocked
with 1% BSA the following day. The coated channels of one m-slide were connected in series with
connector tubings for simultaneous perfusion. The platelet suspension was filled in one reservoir of a
Perfusion Set Black (Ibidi) and the pump was started with unidirectional flow at the highest possible
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pressure 100 mbar) until all channels were filled with the blood-like fluid. Then, the experiment was
started by adjusting the shear rate to approximately 1000/s. The channels were perfused for 10 min
and subsequently washed by perfusing Tyrodes buffer for another 10 min. Platelets were imaged
after performing the perfusion with a Zeiss Apotome microscope and platelet surface coverage was
analysed using ImageJ.
Microvascular thrombus formation
The surgical preparation of the mouse cremaster muscle was performed as described (Baez, 1973).
Mice were anesthetized using a mixture of 100 mg/kg ketamine and 10 mg/kg xylazin. The left femo-
ral artery was cannulated in a retrograde manner to administer FITC-labeled dextran (MW 150 kDa;
Sigma Aldrich). The right cremaster muscle was exposed through a ventral incision of the scrotum.
The muscle was opened ventrally in a relatively avascular zone and spread over the pedestal of a
custom-made microscopy stage. Epididymis and testicle were detached from the cremaster muscle
and placed into the abdominal cavity. Throughout the surgical procedure and in vivo microscopy,
the muscle was superfused with warm saline solution. At the end of each experiment, blood samples
were collected by cardiac puncture to determine systemic cell counts using a hematology analysis
system (ProCyte DX, IDEXX Laboratories ).
Microvascular thrombus formation was induced by phototoxic injury as
described (Rumbaut et al., 2005) with slight modifications. Briefly, after surgical preparation of the
cremaster muscle, 4 ml/kg body weight of a 2.5% solution of FITC-dextran was infused intraarterially
and the exposed the vessel segment under investigation was continuously epi-illuminated with a
wavelength of 488 nm (Polychrome II, TILL Photonics, Gra¨felfing, Germany). An Olympus water
immersion lens (60  /NA 0.9) in an upright microscope (BX50; Olympus Microscopy, Hamburg, Ger-
many) was used to focus the light onto the cremaster muscle and to visualize the microvascular
thrombus formation in real-time. Thrombus formation was induced in one arteriole (25–35 mm) per
experiment by analyzing the time until the first platelet adhesion to the vessel wall (defined as the
onset of thrombus formation) occurred and the time until blood flow ceased (defined as the com-
plete occlusion of the vessel).
Tail bleeding assay
The tail bleeding assay was performed in anesthetized mice directly after the analysis of microvascu-
lar thrombus formation. For this purpose, the distal 2 mm segment of the tail was removed with a
scalpel. Bleeding was monitored by absorbing the bead of blood with a filter paper in 30 s intervals
without touching the wound. Tail bleeding time was defined as the time until hemorrhage ceased.
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